Table 2.

Comparison of target dose achievement in HF clinic and other cardiology OPD

Drugs	Study group	1st month	P value	6th month	P value	12th month	P value
		No. of patients		No. of patients		No. of patients
BB	HF clinic (n = 196)	32 (16.32%)	0.06	76 (38.77%)	0.04	116 (59.18%)	0.0001
	Other cardiology OPD (n = 170)	16 (9.41%)		46 (27.05%)		58 (34.11%)
ACEI/ARB/ARNI	HF clinic (n = 138)	12 (8.69%)	0.04	66 (47.82%)	0.0001	90 (65.21%)	0.0001
	Other cardiology OPD (n = 88)	2 (2.27%)		12 (13.63%)		18 (20.45%)
MRA	HF clinic (n = 152)	140 (92.10%)	0.34	144 (94.73%)	0.35	144 (94.73%)	0.46
	Other cardiology OPD (n = 122)	110 (90.16%)		112 (91.80%)		116 (95%)

The attainment of target doses of the disease modifying drugs and their comparison between the study groups

BB beta blockers, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, ARNI angiotensin receptor neprilysin inhibitor, MRA mineralocorticoid receptor antagonist